FACTS ABOUT METABOLIC SYNDROME AND BLACKCURRANTS
• Metabolic Syndrome is considered to increase the risk of developing cardiovascular disease and diabetes and
has been one of the most popular health issues among western countries.
• It has been prevailing in western countries and up to 47million people in U.S. and 19.6 million in Japan are suffering from metabolic syndrome.
• There have been significant studies conducted in Japan indicating that blackcurrant anthocyanins could be effective to Metabolic Syndrome.
• In 2004, a team of scientists from Doshisha University, Biomakers, San-Ei Gen F.F.I., Inc., Kyoto University and Nagoya University found data suggesting that Anthocyanins from Cassis have a potency of unique therapeutic advantage and also have important implications for preventing obesity and diabetes.
• In the following year of 2005, scientists from Doshisha University, Biomakers, Kyoto Prefectural University and Nagoya University did studies which provided an overview of the gene expression profiles in human adipocytes treated with Anthocyanins and demonstrated that Anthocyanins can regulate adipocytokine gene expression to ameliorate adipocyte function related with obesity and diabetes that merit further investigation.
• Then in 2007, a group from Chubu University, San-Ei Gen F.F.I., Inc. Kobe University, Nagoya University did studies with findings indicating Cassis Anthocyanin of C3G has significant potency in an anti-diabetic effect through the regulation of Glut4-RBP4 system and the related inflammatory adipocytokines.